Table 2.
Perioperative outcomes.
| Total (n = 75) | Non-ECMO (n = 54) | Pro-ECMO (n = 21) | P -value | |
|---|---|---|---|---|
| Length of mechanical ventilation, days (range) | 3 (1–6) | 2 (1–5) | 4 (2–7) | 0.967 |
| Time in ICU, days (range) | 18 (12–29) | 17 (12–29) | 20 (15–29) | 0.165 |
| Length of hospital stay, days (range) | 44 (29–57) | 41 (28–57) | 45 (35–60) | 0.409 |
| Comorbidities, n (%) | ||||
| PGD 3 at 48 or 72 h | 10 (13.3) | 8 (14.8) | 2 (9.5) | 0.716 |
| Post-operative hemodialysis | 1 (1.3) | 1 (1.9) | 0 (0) | 1.000 |
| Revision surgery | 4 (5.3) | 1 (1.9) | 3 (14.3) | 0.064 |
| VTE | 13 (17.3) | 8 (14.8) | 5 (23.8) | 0.497 |
| Airway complications | 15 (20.0) | 12 (22.2) | 3 (14.3) | 0.535 |
| Fungus infection | 16 (21.3) | 13 (24.1) | 3 (14.3) | 0.532 |
| Pulmonary infection | 18 (24.0) | 12 (22.2) | 6 (28.6) | 0.561 |
| Acute rejection | 11 (14.7) | 7 (13.0) | 4 (19.0) | 0.489 |
| Chronic lung allograft dysfunction | 9 (12.0) | 5 (9.3) | 4 (19.0) | 0.256 |
| 30-day survival, n (%) | 70 (93.3) | 50 (92.6) | 20 (95.2) | 1.000 |
| 90-day survival, n (%) | 64 (85.3) | 44 (81.5) | 20 (95.2) | 0.251 |
ICU, intensive care unit; PGD, primary graft dysfunction; VTE, venous thromboembolism.